Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001209191-23-050379

Chief Executive Officer acquired 2,550 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Alder Matthias · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-20 Exercise or conversion : show line 1 in the form +2,550 5,850 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-20 Exercise or conversion : show line 2 in the form Restricted Stock Units −2,550 7,650 D
Loading xslF345X05/doc4.xml…